Genoskin
1 known investors
Genoskin offers MANTIS, a spatial biology platform that performs multiplex 3D imaging analysis of human skin tissue to study immune cell responses to vaccines, drugs, and cosmetics. The platform enables automated, unbiased profiling of immune cells within their tissue context using fluorescence-based imaging and proprietary computational analysis.
Investors · 1
Frequently asked questions
- What does Genoskin do?
- Genoskin offers MANTIS, a spatial biology platform that performs multiplex 3D imaging analysis of human skin tissue to study immune cell responses to vaccines, drugs, and cosmetics. The platform enables automated, unbiased profiling of immune cells within their tissue context using fluorescence-based imaging and proprietary computational analysis.
- Who are Genoskin's investors?
- Genoskin's investors include Grand Sud Ouest Capital.